First Manhattan CO Roivant Sciences Ltd. Transaction History
First Manhattan CO
- $31.9 Billion
- Q3 2024
A detailed history of First Manhattan CO transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, First Manhattan CO holds 11,900 shares of ROIV stock, worth $143,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,900
Previous 11,400
4.39%
Holding current value
$143,871
Previous $120,000
14.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$797 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$795 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$654 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$504 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$428 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.52B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...